392 results match your criteria: "Moorfields Biomedical Research Centre[Affiliation]"
PLoS One
December 2024
UCL Institute of Ophthalmology, London, United Kingdom.
Photoreceptors (PRs) are metabolically demanding and packed at high density, which presents a challenge for nutrient exchange between the associated vascular beds and the tissue. Motivated by the ambition to understand the constraints under which PRs function, in this study we have drawn together diverse physiological and anatomical data in order to generate estimates of the rates of ATP production per mm2 of retinal surface area. With the predictions of metabolic demand in the companion paper, we seek to develop an integrated energy budget for the outer retina.
View Article and Find Full Text PDFEye (Lond)
November 2024
National Institute of Health Research Moorfields Biomedical Research Centre and Clinical Research Facility, Moorfields Eye Hospital, London, UK.
Objective: To estimate inter-session coefficient of repeatability (CR) of visual function and OCTA metrics over 3 months in diabetic macular ischaemia (DMI) in stable laser-treated proliferative diabetic retinopathy (PDR) patients.
Methods: This prospective study recruited patients with stable PDR for at least 6 months following pan-retinal photocoagulation with visual acuity of at least 54 ETDRS letters. DMI was confirmed on OCTA as FAZ area of at least 0.
Clin Ophthalmol
November 2024
Bayer plc, Reading, UK.
Purpose: The inclusion of ranibizumab biosimilars into National Health Service England commissioning recommendations published in 2022 created a need for expert guidance to optimize treatment outcomes in patients with neovascular age-related macular degeneration (nAMD) who otherwise may not have received first-line ranibizumab. This article provides a consensus treatment pathway supporting timely identification and management of a suboptimal response to these therapies, thereby aiming to facilitate clinically meaningful outcomes and efficient management of service capacity under specific circumstances where ranibizumab biosimilars may be initiated as a first-line treatment.
Methods: Two structured round-table meetings of UK medical retina specialists were held in person and virtually on September 22 and November 3, 2022, respectively.
JAMA Netw Open
October 2024
Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.
Importance: Age-related macular degeneration (AMD) is the leading cause of blindness among people aged 50 years or older worldwide. There is a need for new strategies for the prevention and treatment of AMD. There is some limited evidence to suggest the possibility of a protective association of dementia medications with the development of some types of AMD, but the evidence is weak.
View Article and Find Full Text PDFArXiv
July 2024
Bioinformatics and Computational Bioscience Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Iterative Bleaching Extends multipleXity (IBEX) is a versatile method for highly multiplexed imaging of diverse tissues. Based on open science principles, we created the IBEX Knowledge-Base, a resource for reagents, protocols and more, to empower innovation.
View Article and Find Full Text PDFPLOS Digit Health
October 2024
Population, Policy and Practice Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Patient portals allowing access to electronic health care records and services can inform and empower but may widen existing sociodemographic inequities. We aimed to describe associations between activation of a paediatric patient portal and patient race/ethnicity, socioeconomic status and markers of previous engagement with health care. A retrospective single site cross-sectional study was undertaken to examine patient portal adoption amongst families of children receiving care for chronic or complex disorders within the United Kingdom.
View Article and Find Full Text PDFBMJ Open Ophthalmol
October 2024
Roche Products Ltd, Welwyn Garden City, UK.
Aims: To identify baseline characteristics that best correlate to treatment interval for naive neovascular age-related macular degeneration patients treated with faricimab in the first year (Y1) of the TENAYA and LUCERNE phase 3 trials, and to further understand how these characteristics may impact treatment intervals.
Methods: This post-hoc analysis of Y1 data from the TENAYA and LUCERNE trials evaluated ocular baseline characteristics associated with Y1 treatment intervals. Patients were categorised into three subgroups based on their Y1 treatment interval: Q16W, Q12W or Q8W.
Br J Ophthalmol
September 2024
The Hong Kong Polytechnic University, Hong Kong, China
Ophthalmic Physiol Opt
November 2024
Cameron Optometry, Edinburgh, UK.
Eye (Lond)
September 2024
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
BMC Microbiol
September 2024
Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Sankara Nethralaya, 18 College Road, Chennai, 600 006, Tamil Nadu, India.
Purpose: To determine the association of gut microbiome diversity and sight-threatening diabetic retinopathy (STDR) amongst patients with pre-existing diabetes.
Methods: A cross-sectional study was performed, wherein 54 participants selected in total were placed into cases cohort if diagnosed with STDR and those without STDR but had a diagnosis of diabetes mellitus of at least 10-year duration were taken as controls. Statistical analysis comparing the gut microbial alpha diversity between cases and control groups as well as patients differentiated based on previously hypothesized Bacteroidetes/Firmicutes(B/F) ratio with an optimal cut-off 1.
Ophthalmol Sci
June 2024
Novartis Pharmaceuticals AG, Basel, Switzerland.
Purpose: To evaluate the performance of a disease activity (DA) model developed to detect DA in participants with neovascular age-related macular degeneration (nAMD).
Design: Post hoc analysis.
Participants: Patient dataset from the phase III HAWK and HARRIER (H&H) studies.
JMIR Diabetes
September 2024
Health Technology Assessment Unit, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Background: Diabetic retinopathy (DR) affects about 25% of people with diabetes in Canada. Early detection of DR is essential for preventing vision loss.
Objective: We evaluated the real-world performance of an artificial intelligence (AI) system that analyzes fundus images for DR screening in a Quebec tertiary care center.
Eye (Lond)
December 2024
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Eye (Lond)
December 2024
Gavin Herbert Eye Institute, University of California, Irvine, Irvine, CA, USA.
Ophthalmology
August 2024
Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Sunderland Eye Infirmary, Sunderland, United Kingdom. Electronic address:
Topic: To assess the anatomic and visual effects of facedown positioning (FDP) advice in patients undergoing vitrectomy with gas tamponade for idiopathic full-thickness macular holes (FTMHs) and to explore differential treatment effects by macular hole size and FDP duration.
Clinical Relevance: The necessity and duration of FDP for FTMH closure remain contentious, with no consensus guidelines.
Methods: Prospectively registered systematic review and individual patient data (IPD) meta-analysis of randomized controlled trials comparing FDP with no FDP (nFDP) across the MEDLINE, Embase, and Cochrane Library databases and clinical trial registries from January 2000 to March 2023 (CRD42023395152).
Ophthalmology
August 2024
Ophthalmology Unit, Department of Experimental Medicine, Università di Roma "Tor Vergata," Rome, Italy.
Topic: To provide an overview on the incidence of Acanthamoeba keratitis (AK).
Clinical Relevance: Although being a sight-threatening cause of infectious keratitis, a comprehensive assessment of the incidence of AK is lacking.
Methods: Incidence of AK was computed as the number of eyes with AK per health care center, per year (annualized center incidence [ACI]).
Am J Ophthalmol
July 2024
From the Population, Policy and Practice Programme, UCL GOS Institute of Child Health (P.U., J.S.R., A.L.S.); Great Ormond Street Hospital for Children NHS Trust (N.T., J.S.R., A.L.S.); National Institute for Health Research Great Ormond Street Biomedical Research Centre (J.S.R., A.L.S.); Ulverscroft Vision Research Group (J.S.R., A.L.S.), London. Electronic address:
Purpose: We investigated the impact of operator parameters on the diagnostic performance of anterior-segment optical coherence tomography (AS-OCT) in anterior uveitis.
Design: Prospective comparative diagnostic analysis.
Methods: Setting: Single site.
Background/aims: Recent decades have seen significant advances in both structural and functional testing of retinal disease. However, the current clinical value of specific testing modalities, as well as future trends, need to be clearly identified in order to highlight areas for further development in routine care and clinical trials.
Methods: We designed a modified two-round Delphi study to obtain the opinion of a multidisciplinary group of 33 international experts involved in the field of retinal disease management/research to determine the level of agreement and consensus regarding the value and performance of specific structural and functional testing methods for retinal disease.
Objectives: This study aimed to evaluate the safety of dichoptic balanced binocular viewing (BBV) for amblyopia in children, plus feasibility, adherence, acceptability, trial methodology and clinical measures of visual function.
Design: We carried out an observer-masked parallel-group phase 2a feasibility randomised controlled trial.
Setting: Two study sites, a secondary/tertiary and a community site.
Psychiatry Res
September 2024
NIHR Moorfields Biomedical Research Centre, London, United Kingdom; Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
We examined the relationship between genetic risk for schizophrenia (SZ), using polygenic risk scores (PRSs), and retinal morphological alterations. Retinal structural and vascular indices derived from optical coherence tomography (OCT) and color fundus photography (CFP) and PRSs for SZ were analyzed in N = 35,024 individuals from the prospective cohort study, United Kingdom Biobank (UKB). Results indicated that macular ganglion cell-inner plexiform layer (mGC-IPL) thickness was significantly inversely related to PRS for SZ, and this relationship was strongest within higher PRS quintiles and independent of potential confounders and age.
View Article and Find Full Text PDFStud Health Technol Inform
July 2024
Centre for Public Health, Queen's University of Belfast.
This study formed part of a diagnostic test accuracy study to quantify the ability of three index home monitoring (HM) tests (one paper-based and two digital tests) to identify reactivation in Neovascular age-related macular degeneration (nAMD). The aim of the study was to investigate views about acceptability and explore adherence to weekly HM. Semi-structured interviews were held with 98 patients, family members, and healthcare professionals.
View Article and Find Full Text PDFEye (Lond)
November 2024
Department of Surgery, Division of Ophthalmology, McMaster University, Hamilton, ON, Canada.
Objective: The fragility index (FI) of a meta-analysis evaluates the extent that the statistical significance can be changed by modifying the event status of individuals from included trials. Understanding the FI improves the interpretation of the results of meta-analyses and can help to inform changes to clinical practice. This review determined the fragility of ophthalmology-related meta-analyses.
View Article and Find Full Text PDFNat Med
October 2024
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.